Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Sep 15;13:970588. doi: 10.3389/fimmu.2022.970588

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Yang, Zhang, Ding, Hu, Sun, Peng, Chu, Xie, Mei, Shao and Xiao

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Performance comparison of GILncSig with KRAS paradigm and lncRNA-related prognostic models derived from other studies. (A) The proportion of KRAS mutations in high- and low-risk groups in the training set, testing set and the TCGA cohort. (B) Kaplan-Meier curve analysis of overall survival for PDAC patients belonging to KRAS Mutation/GU-like group, KRAS Wild/GU-like group and KRAS Wild/GS-like group for patients classified by KRAS mutation status and GILncSig. Statistical analysis was performed using the log-rank test. (C) The ROC analysis at 3 years of overall survival for GILncSig, WuLncSig, and ShiLncSig.